Crossmark

Age and hematologic parameters can predict prolonged glucocorticoid replacement after remission of cushing disease and adrenal Cushing’s syndrome: A nationwide cohort study

Crossref DOI link: https://doi.org/10.1007/s11102-026-01665-x

Published Online: 2026-03-25

Published Print: 2026-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Agrawal, Nidhi

Shah, Shruti N.

Kushnir, Shiri

Shochat, Tzipora

Rudman, Yaron

Fleseriu, Maria

Akirov, Amit
License Information

Text and Data Mining valid from 2026-03-25

Version of Record valid from 2026-03-25
More Information

Article History

Received: 5 February 2026

Accepted: 11 March 2026

First Online: 25 March 2026

Declarations

:

: The study was conducted in accordance with the Declaration of Helsinki and approved by the Rabin Medical Center Ethics Review Board, which granted a waiver of informed consent as data were anonymized.

: NA is an advisory board member at Xeris, Amryt, and Camurus and has received research support from Amryt, Recordati, and Ascendis. MF has received research support to her institution from Crinetics and Sparrow and has received consulting fees from Crinetics, Lundbeck, Recordati, Sparrow, and Xeris. AA is an advisory board member for Medison, CTS Pharma, and Neopharm and has received scientific consulting fees from these companies. The remaining authors have no relevant financial interests to disclose.

Document is current

Any future updates will be listed below